Cargando…
Correction: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Georg Thieme Verlag KG
2021
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738085/ https://www.ncbi.nlm.nih.gov/pubmed/36510503 http://dx.doi.org/10.1055/a-1536-7577 |
| _version_ | 1784847449641189376 |
|---|---|
| author | Römer, Thomas Bitzer, Johannes Egarter, Christian Hadji, Peyman Kiechle, Marion Kramer, Heike Oppelt, Patricia G. Peters, Klaus Stute, Petra Schaudig, Katrin Wiegratz, Inka Regidor, Pedro-Antonio |
| author_facet | Römer, Thomas Bitzer, Johannes Egarter, Christian Hadji, Peyman Kiechle, Marion Kramer, Heike Oppelt, Patricia G. Peters, Klaus Stute, Petra Schaudig, Katrin Wiegratz, Inka Regidor, Pedro-Antonio |
| author_sort | Römer, Thomas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9738085 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Georg Thieme Verlag KG |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97380852022-12-11 Correction: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone Römer, Thomas Bitzer, Johannes Egarter, Christian Hadji, Peyman Kiechle, Marion Kramer, Heike Oppelt, Patricia G. Peters, Klaus Stute, Petra Schaudig, Katrin Wiegratz, Inka Regidor, Pedro-Antonio Geburtshilfe Frauenheilkd Georg Thieme Verlag KG 2021-06-29 /pmc/articles/PMC9738085/ /pubmed/36510503 http://dx.doi.org/10.1055/a-1536-7577 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
| spellingShingle | Römer, Thomas Bitzer, Johannes Egarter, Christian Hadji, Peyman Kiechle, Marion Kramer, Heike Oppelt, Patricia G. Peters, Klaus Stute, Petra Schaudig, Katrin Wiegratz, Inka Regidor, Pedro-Antonio Correction: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone |
| title | Correction: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone |
| title_full | Correction: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone |
| title_fullStr | Correction: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone |
| title_full_unstemmed | Correction: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone |
| title_short | Correction: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone |
| title_sort | correction: oral progestins in hormonal contraception: importance and future perspectives of a new progestin only-pill containing 4 mg drospirenone |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738085/ https://www.ncbi.nlm.nih.gov/pubmed/36510503 http://dx.doi.org/10.1055/a-1536-7577 |
| work_keys_str_mv | AT romerthomas correctionoralprogestinsinhormonalcontraceptionimportanceandfutureperspectivesofanewprogestinonlypillcontaining4mgdrospirenone AT bitzerjohannes correctionoralprogestinsinhormonalcontraceptionimportanceandfutureperspectivesofanewprogestinonlypillcontaining4mgdrospirenone AT egarterchristian correctionoralprogestinsinhormonalcontraceptionimportanceandfutureperspectivesofanewprogestinonlypillcontaining4mgdrospirenone AT hadjipeyman correctionoralprogestinsinhormonalcontraceptionimportanceandfutureperspectivesofanewprogestinonlypillcontaining4mgdrospirenone AT kiechlemarion correctionoralprogestinsinhormonalcontraceptionimportanceandfutureperspectivesofanewprogestinonlypillcontaining4mgdrospirenone AT kramerheike correctionoralprogestinsinhormonalcontraceptionimportanceandfutureperspectivesofanewprogestinonlypillcontaining4mgdrospirenone AT oppeltpatriciag correctionoralprogestinsinhormonalcontraceptionimportanceandfutureperspectivesofanewprogestinonlypillcontaining4mgdrospirenone AT petersklaus correctionoralprogestinsinhormonalcontraceptionimportanceandfutureperspectivesofanewprogestinonlypillcontaining4mgdrospirenone AT stutepetra correctionoralprogestinsinhormonalcontraceptionimportanceandfutureperspectivesofanewprogestinonlypillcontaining4mgdrospirenone AT schaudigkatrin correctionoralprogestinsinhormonalcontraceptionimportanceandfutureperspectivesofanewprogestinonlypillcontaining4mgdrospirenone AT wiegratzinka correctionoralprogestinsinhormonalcontraceptionimportanceandfutureperspectivesofanewprogestinonlypillcontaining4mgdrospirenone AT regidorpedroantonio correctionoralprogestinsinhormonalcontraceptionimportanceandfutureperspectivesofanewprogestinonlypillcontaining4mgdrospirenone |